 effect interferon-gamma therapi thyroid function t-lymphocyt subpopul induct autoantibodi treatment human leucocyt interferon ifn alpha develop thyroid autoimmun hypothyroid certain phenomenon result contamin ifn gamma hla class II antigen express t-lymphocyt subject femal male mean age yr rang chronic activ hepat recombin human ifn gamma rhifn gamma im times/week week goiter present patient histori famili histori autoimmun diseas serial thyroid function serum free thyroid hormon index free tsh subsequ follow-up period yr normal patient adequ serial sampl studi serolog lymphocyt subpopul none patient rhifn gamma thyroglobulin microsom antibodi patient antinuclear smooth muscl autoantibodi rhifn gamma treatment treatment rhifn gamma signific increas t-lymphocyt hla-dr-posit t-cell equal proport t-cell DR posit percentag hla-dr-posit t-cell elev discontinu rhifn gamma rhifn gamma treatment decreas number granulocyt receptor-posit cell conclus thyroid dysfunct thyroid autoimmun patient dose rhifn gamma induct autoantibodi